ArriVent BioPharma (NASDAQ:AVBP) Trading Down 4.7% - Time to Sell? - MarketBeat
Yesterday • Google News
ArriVent BioPharma, Inc. Common Stock (AVBP)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 799.61M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 36.37
52W Low
$ 15.47
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
19.959
200-Day MA
22.5629
52 Week High
36.37
52 Week Low
15.47
About AVBP
ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancer.
Employees
52
Headquarters
Newtown Square, PA
CEO
Dr. Zhengbin Yao Ph.D.